Small Biopharms Face Unique Challenges: Outsourcing in Early-Stage Drug Development

June 15, 2003
JanHasker Jonkman

,
Bruce Babbitt

,
Paul McKim

BioPharm International, BioPharm International-06-01-2003, Volume 16, Issue 6

by Bruce Babbitt, PAREXEL International, JanHasker Jonkman, and Paul McKim By partnering with external drug development service providers, small biopharmaceutical start-ups can move their products out of the lab and into clinical development more efficiently.